GO:0004462 lactoylglutathione lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004462 lactoylglutathione lyase activity catalyzes the isomerization of (R)-S-lactoylglutathione to glutathione and methylglyoxal, the central step of the glyoxalase system.
• The enzyme, historically called glyoxalase I, is a metalloenzyme that in many bacteria and some eukaryotes depends on nickel or zinc for catalysis.
• By detoxifying methylglyoxal, lactoylglutathione lyase protects cells from advanced glycation end-product (AGE) damage and supports survival under metabolic stress.
• Dysregulation of lactoylglutathione lyase activity is linked to inflammatory immune responses, diabetic retinopathy, and cancer metabolism.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the enzyme's role in disease and to validate it as a therapeutic target.
• Accurate measurement of lactoylglutathione lyase activity requires careful spectrophotometric or fluorometric assays that distinguish it from glyoxalase II.
Description
Lactoylglutathione lyase activity (GO:0004462) is a molecular function that catalyzes the conversion of (R)-S-lactoylglutathione into glutathione and methylglyoxal. This reaction is the first and rate-limiting step of the glyoxalase system, a ubiquitous pathway that detoxifies methylglyoxal, a highly reactive byproduct of glycolysis. The enzyme is also known as glyoxalase I, aldoketomutase, or methylglyoxalase, reflecting its historical discovery and multiple catalytic roles. Because methylglyoxal is a potent glycating agent that damages proteins and nucleic acids, lactoylglutathione lyase activity is critical for cellular protection against metabolic stress. Researchers study this activity to understand how cells maintain redox balance, how pathogens survive in hostile environments, and how metabolic dysfunction contributes to diseases such as diabetes and cancer. The enzyme's dependence on metal cofactors, particularly nickel or zinc, has also made it a model for metalloenzyme evolution and drug targeting.
lactoylglutathione lyase activity At A Glance
| GO ID | GO:0004462 |
|---|---|
| GO term | lactoylglutathione lyase activity |
| Ontology | molecular_function |
| Synonym | glyoxalase I activity; aldoketomutase activity; methylglyoxalase activity; (R)-S-lactoylglutathione methylglyoxal-lyase (isomerizing) activity |
| Major function | Catalyzes the isomerization of (R)-S-lactoylglutathione to glutathione and methylglyoxal, the first step of the glyoxalase system. |
| Cofactors | Typically requires a divalent metal ion such as nickel or zinc for catalysis. |
| Pathway context | Glyoxalase system; methylglyoxal detoxification; glutathione metabolism. |
| Cellular localization | Cytosol and mitochondria in eukaryotes; cytoplasm in bacteria. |
What Is GO:0004462?
According to the Gene Ontology, lactoylglutathione lyase activity (GO:0004462) is defined as the catalysis of the reaction: (R)-S-lactoylglutathione = glutathione + methylglyoxal. In other words, it is an isomerase that converts a glutathione-bound hemithioacetal into free glutathione and methylglyoxal, thereby completing the first half of the glyoxalase detoxification pathway. This activity is synonymous with glyoxalase I, aldoketomutase, ketone-aldehyde mutase, and methylglyoxalase.
Why Is lactoylglutathione lyase activity Important in Cell Biology?
Lactoylglutathione lyase activity is essential for controlling methylglyoxal, a reactive dicarbonyl that accumulates during glycolysis and causes protein glycation, DNA damage, and cellular toxicity. By converting (R)-S-lactoylglutathione to glutathione and methylglyoxal, the enzyme initiates a two-step detoxification that ultimately yields D-lactate. This activity influences immune responses, as nonenzymatic lysine D-lactylation by the substrate SLG can dampen inflammation. In diabetes, upregulation of glyoxalase I protects retinal pigment epithelial cells from methylglyoxal-induced death. In cancer, altered glyoxalase I expression supports metabolic reprogramming and chemoresistance. Thus, understanding lactoylglutathione lyase activity is crucial for developing therapies against metabolic, inflammatory, and neoplastic diseases.
• Detoxifies methylglyoxal, preventing advanced glycation end-product (AGE) formation and cellular damage.
• Supports pathogen survival in nutrient-rich environments, as shown in Salmonella.
• Modulates inflammatory immune responses through nonenzymatic D-lactylation of proteins.
• Protects against diabetic retinopathy by reducing methylglyoxal-induced oxidative stress.
• Coordinates de novo serine metabolism, linking glyoxalase activity to one-carbon metabolism.
• Serves as a potential drug target in cancer and infectious diseases.
• Provides a model for nickel-dependent metalloenzyme evolution and catalysis.
• Enables accurate measurement of glyoxalase pathway flux in metabolic studies.
What Happens During lactoylglutathione lyase activity?
Substrate Binding and Hemithioacetal Formation
In simple terms: First, methylglyoxal and glutathione spontaneously combine to form a hemithioacetal, which is the actual substrate for the enzyme.
Methylglyoxal, a byproduct of glycolysis, reacts nonenzymatically with reduced glutathione to form (R)-S-lactoylglutathione, a hemithioacetal. This spontaneous step is rapid and ensures a supply of substrate for lactoylglutathione lyase. The enzyme then binds this substrate in its active site, which contains a divalent metal ion, typically nickel or zinc, coordinated by conserved residues. In bacteria such as Salmonella, this binding is critical for survival in nutrient-rich environments.
Isomerization and Product Release
In simple terms: The enzyme rearranges the substrate to release glutathione and methylglyoxal, completing the first half of the detoxification pathway.
Lactoylglutathione lyase catalyzes the isomerization of (R)-S-lactoylglutathione to glutathione and methylglyoxal. This reaction is reversible but physiologically favors product formation because methylglyoxal is rapidly consumed by subsequent steps or by glycation reactions. The released glutathione is recycled, while methylglyoxal can either be further detoxified by glyoxalase II to D-lactate or act as a signaling molecule. The catalytic mechanism involves metal-assisted polarization of the substrate, facilitating proton transfer and bond rearrangement.
Role in the Glyoxalase System
In simple terms: This enzyme is the first step of a two-enzyme system that converts toxic methylglyoxal into harmless D-lactate.
The glyoxalase system consists of lactoylglutathione lyase (glyoxalase I) and hydroxyacylglutathione hydrolase (glyoxalase II). Glyoxalase I produces (R)-S-lactoylglutathione, which glyoxalase II hydrolyzes to D-lactate and glutathione. This pathway is the primary route for methylglyoxal detoxification in most organisms. In mammals, the system also regulates protein D-lactylation, a post-translational modification that can dampen inflammatory responses.
Metabolic Integration and Stress Response
In simple terms: The enzyme connects glycolysis, glutathione metabolism, and serine synthesis to help cells cope with metabolic stress.
Lactoylglutathione lyase activity is integrated with de novo serine metabolism, as glyoxalase 2 coordinates with serine synthesis to manage methylglyoxal flux. Under hyperglycemic conditions, upregulation of glyoxalase I protects cells from methylglyoxal-induced damage, as shown in retinal pigment epithelial cells. In pathogens, the enzyme contributes to survival within host environments by mitigating methylglyoxal toxicity. Thus, this activity is a metabolic hub that links energy metabolism, redox balance, and stress resistance.
Key Genes Involved in GO:0004462 lactoylglutathione lyase activity
The following genes encode proteins with lactoylglutathione lyase activity or are directly involved in its regulation and pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLO1 | Encodes glyoxalase I, the primary enzyme with lactoylglutathione lyase activity in humans. | Target for diabetic retinopathy and cancer metabolism studies. |
| GLO2 | Encodes glyoxalase II, which hydrolyzes S-lactoylglutathione to D-lactate. | Coordinates with GLO1 in methylglyoxal detoxification. |
| GloA | Bacterial glyoxalase I, often nickel-dependent. | Model for metalloenzyme evolution and antibacterial targeting. |
| GloB | Bacterial glyoxalase II. | Studied for its role in pathogen survival. |
| glo1 | Yeast glyoxalase I. | Used in genetic screens for methylglyoxal resistance. |
| GLO1 (Salmonella) | Contributes to survival in nutrient-rich environments. | Virulence factor model in Salmonella. |
| GLO1 (Arabidopsis) | Plant glyoxalase I involved in stress responses. | Model for plant methylglyoxal detoxification. |
| GLO1 (Drosophila) | Regulates methylglyoxal levels and lifespan. | Model for aging and neurodegeneration. |
| GLO1 (C. elegans) | Modulates methylglyoxal detoxification and stress resistance. | Model for metabolic stress. |
| GLO1 (Zebrafish) | Required for embryonic development under metabolic stress. | Model for developmental glyoxalase functions. |
| GLO1 (Mouse) | Knockout leads to methylglyoxal accumulation and phenotypes. | Model for diabetic complications. |
| GLO1 (Rat) | Studied in retinal pigment epithelial cells. | Model for retinopathy. |
| GLO1 (Bovine) | Used in enzymatic assays. | Source for purified enzyme. |
| GLO1 (E. coli) | Nickel-dependent glyoxalase I. | Model for metal coordination. |
| GLO1 (Human) | Zinc-dependent glyoxalase I. | Drug target for cancer. |
| GLO1 (Plasmodium) | Potential antimalarial target. | Parasite methylglyoxal detoxification. |
| GLO1 (Leishmania) | Trypanothione-dependent glyoxalase I. | Drug target for leishmaniasis. |
| GLO1 (Mycobacterium) | Nickel-dependent enzyme. | Target for tuberculosis. |
How Is lactoylglutathione lyase activity Regulated?
Lactoylglutathione lyase activity is regulated at multiple levels. Transcriptionally, GLO1 expression is induced by stress-responsive transcription factors such as Nrf2 and HIF-1α under oxidative or hypoxic conditions. Post-translationally, the enzyme can be modified by phosphorylation and acetylation, affecting its catalytic efficiency. Metabolically, the availability of glutathione and methylglyoxal directly influences flux through the enzyme. In immune cells, nonenzymatic D-lactylation of proteins by the substrate SLG can modulate inflammatory signaling, suggesting feedback regulation. Additionally, glyoxalase 2 coordinates with serine metabolism to balance methylglyoxal levels, indirectly affecting glyoxalase I activity.
lactoylglutathione lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLO1 | Diabetic retinopathy | ARPE-19 cells with GLO1 overexpression or knockout |
| GLO1 | Inflammatory immune responses | Macrophage-specific GLO1 knockout mice |
| GLO1 | Cancer metabolism and chemoresistance | Cancer cell lines with GLO1 knockout or overexpression |
| GloA (Salmonella) | Bacterial virulence | Salmonella infection model with gloA deletion |
| GLO1 | Neurodegeneration (methylglyoxal toxicity) | Drosophila or C. elegans GLO1 mutants |
Diabetic Retinopathy
Methylglyoxal accumulation contributes to retinal pigment epithelial cell death and diabetic retinopathy. Upregulation of glyoxalase 1 (lactoylglutathione lyase) protects these cells via AMPK-dependent mechanisms, reversing mitochondrial dysfunction. Thus, enhancing lactoylglutathione lyase activity is a potential therapeutic strategy for diabetic retinopathy.
Inflammatory and Immune Disorders
Nonenzymatic lysine D-lactylation induced by the glyoxalase II substrate SLG dampens inflammatory immune responses. This modification, which depends on the glyoxalase system, regulates cytokine production and immune cell activation. Dysregulation of lactoylglutathione lyase activity may therefore contribute to autoimmune and inflammatory diseases.
Cancer Metabolism
Cancer cells often upregulate glyoxalase 1 to cope with high glycolytic flux and methylglyoxal stress. This supports cell survival and chemoresistance. Glyoxalase 2 coordinates de novo serine metabolism, linking lactoylglutathione lyase activity to one-carbon metabolism and nucleotide synthesis. Inhibitors of glyoxalase I are being explored as anticancer agents.
Infectious Diseases
In pathogens such as Salmonella, lactoylglutathione lyase contributes to survival in nutrient-rich environments, making it a virulence factor. Bacterial glyoxalases, including nickel-dependent enzymes, are potential targets for new antibiotics. The enzyme's role in methylglyoxal detoxification is critical for pathogen fitness within hosts.
From lactoylglutathione lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLO1 knockout increase methylglyoxal and oxidative stress? | CRISPR knockout in human cell lines (e.g., HEK293, ARPE-19) |
| Does a point mutation in the metal-binding site abolish lactoylglutathione lyase activity? | CRISPR point mutation knock-in in GLO1 locus |
| Does tagging GLO1 with a fluorescent protein affect its localization? | CRISPR knock-in of GFP or HA tag |
| Does GLO1 overexpression protect against diabetic retinopathy? | Overexpression in retinal pigment epithelial cells |
| Does GLO1 knockout affect inflammatory cytokine production? | Macrophage-specific knockout in mice |
| Does bacterial gloA deletion reduce virulence? | Salmonella infection model |
How to Study the lactoylglutathione lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay at 240 nm | Formation of S-lactoylglutathione | Kinetic characterization of glyoxalase I |
| Coupled assay with glyoxalase II | Overall glyoxalase activity | Distinguishing glyoxalase I and II |
| CRISPR knockout | Loss of GLO1 function | Methylglyoxal accumulation and stress response |
| CRISPR point mutation | Effect of metal-binding site mutations | Catalytic mechanism studies |
| CRISPR knock-in (tag) | Protein localization and interactions | Live-cell imaging |
| Overexpression | Gain of function | Protection against methylglyoxal toxicity |
| Metabolomics (LC-MS) | Methylglyoxal, SLG, D-lactate levels | Pathway flux analysis |
| Anti-D-lactyllysine western blot | Protein D-lactylation | Inflammatory signaling studies |
Enzymatic Activity Assays
Lactoylglutathione lyase activity is measured spectrophotometrically by monitoring the formation of S-lactoylglutathione at 240 nm or by coupled assays with glyoxalase II. These methods distinguish glyoxalase I from glyoxalase II and allow kinetic characterization. Researchers must control for nonenzymatic hemithioacetal formation.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 knockout of GLO1 in cell lines and animal models reveals its role in methylglyoxal detoxification and disease. Point mutations in the metal-binding residues can dissect catalytic mechanism. Knock-in of tagged versions enables localization and interaction studies.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics quantifies methylglyoxal, S-lactoylglutathione, and D-lactate to assess pathway flux. Isotope tracing can link glyoxalase activity to serine and one-carbon metabolism. These methods are essential for understanding metabolic integration.
Protein D-Lactylation Detection
Nonenzymatic lysine D-lactylation can be detected by western blot with anti-D-lactyllysine antibodies or by mass spectrometry. This modification reflects glyoxalase substrate availability and immune modulation. It is a novel readout for lactoylglutathione lyase activity in inflammation.
How CRISPR Can Be Used to Study GO:0004462 lactoylglutathione lyase activity
Knockout
CRISPR knockout of GLO1 eliminates lactoylglutathione lyase activity, leading to methylglyoxal accumulation and increased glycation stress. This model is used to study the enzyme's role in diabetic retinopathy, cancer, and immune responses. Knockout cells show hypersensitivity to glycolytic stress.
Point Mutation
Point mutations in the metal-binding residues of GLO1 (e.g., His, Glu, or Cys ligands) abolish or reduce catalytic activity. These models help dissect the contribution of nickel versus zinc coordination. They are valuable for understanding metalloenzyme mechanism.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous GLO1 locus allows real-time tracking of protein localization and interactions. This approach preserves native regulation and is ideal for imaging studies.
Overexpression
Overexpression of GLO1 enhances methylglyoxal detoxification and protects cells from oxidative stress. This model is used to test therapeutic potential in diabetic retinopathy and neurodegeneration. It also helps identify downstream effects on inflammation and metabolism.
How EDITGENE Supports lactoylglutathione lyase activity Research
Researchers studying lactoylglutathione lyase activity-related genes often need to determine whether a candidate gene is causally involved in methylglyoxal detoxification, metabolic stress resistance, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and drug target discovery.
Contact EDITGENE today to design your custom CRISPR model for lactoylglutathione lyase activity research.
Frequently Asked Questions About lactoylglutathione lyase activity
What is lactoylglutathione lyase activity?
Lactoylglutathione lyase activity (GO:0004462) is the catalysis of the reaction (R)-S-lactoylglutathione = glutathione + methylglyoxal, the first step of the glyoxalase system.
What genes are involved in lactoylglutathione lyase activity?
The primary gene is GLO1, encoding glyoxalase I. Other related genes include GLO2 (glyoxalase II) and bacterial gloA.
What is the function of glyoxalase I?
Glyoxalase I detoxifies methylglyoxal by converting (R)-S-lactoylglutathione to glutathione and methylglyoxal, protecting cells from glycation damage.
How is lactoylglutathione lyase activity measured?
It is measured spectrophotometrically at 240 nm or by coupled assays with glyoxalase II.
What diseases are associated with lactoylglutathione lyase activity?
It is linked to diabetic retinopathy, inflammatory disorders, cancer metabolism, and bacterial virulence.
What cofactors does lactoylglutathione lyase require?
It typically requires a divalent metal ion such as nickel or zinc.
Can CRISPR be used to study lactoylglutathione lyase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect its function.
What is the difference between glyoxalase I and glyoxalase II?
Glyoxalase I (lactoylglutathione lyase) produces S-lactoylglutathione, while glyoxalase II hydrolyzes it to D-lactate and glutathione.
Is lactoylglutathione lyase activity important for immune responses?
Yes, nonenzymatic D-lactylation by the substrate SLG dampens inflammatory immune responses.
How does methylglyoxal affect cells?
Methylglyoxal is a reactive dicarbonyl that causes protein glycation, DNA damage, and cellular toxicity if not detoxified.
Conclusion
Lactoylglutathione lyase activity (GO:0004462) is a fundamental molecular function that safeguards cells from methylglyoxal toxicity and integrates glycolysis with glutathione and serine metabolism. Its dysregulation contributes to diabetic complications, inflammatory diseases, and cancer, making it a compelling therapeutic target. CRISPR-based models are indispensable for dissecting its mechanism and validating its role in disease. EDITGENE's comprehensive services empower researchers to generate precise genetic models and accelerate discoveries in glyoxalase biology.
References
- 1. Zhao Q et al.. 2025. Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses.. Cell Res 35(2):97-116 PMID: 39757301
- 2. Boer JL et al.. 2014. Nickel-dependent metalloenzymes.. Arch Biochem Biophys 544:142-52 PMID: 24036122
- 3. Wattt RK et al.. 1999. Nickel-binding proteins.. Cell Mol Life Sci 56(7-8):604-25 PMID: 11212309
- 4. Suttisansanee U et al.. 2011. Bacterial glyoxalase enzymes.. Semin Cell Dev Biol 22(3):285-92 PMID: 21310258
- 5. Arai M et al.. 2014. Measurement of glyoxalase activities.. Biochem Soc Trans 42(2):491-4 PMID: 24646266
- 6. Trujillo MN et al.. 2025. Glyoxalase 2 Coordinates de Novo Serine Metabolism.. Chembiochem 26(7):e202401086 PMID: 39988553
- 7. Sekar P et al.. 2023. Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: Reversing mitochondrial dysfunction and upregulating glyoxalase 1.. Redox Biol 64:102786 PMID: 37348156
- 8. Chakraborty S et al.. 2015. Lactoylglutathione lyase, a critical enzyme in methylglyoxal detoxification, contributes to survival of Salmonella in the nutrient rich environment.. Virulence 6(1):50-65 PMID: 25517857
